NCT01745224View on ClinicalTrials.gov

Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma

NATerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Melasma
Interventions
DEVICE

Revlite Q switched Nd:YAG

Revlite Q switched Nd:YAG 1064nm

DEVICE

Trivantage Q switched Nd: YAG

Trivantage Q switched Nd: YAG 1064nm

Trial Locations (1)

10028

NY Laser and Skin Care, New York

Sponsors

Lead Sponsor

Cynosure, Inc.
All Listed Sponsors
lead

Cynosure, Inc.

INDUSTRY

NCT01745224 - Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma | Biotech Hunter | Biotech Hunter